Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Austria
Clinical trial register · Austria

Clinical Trials in Austria

Every study on the ClinicalTrials.gov registry that lists a site in Austria and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1586 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
1586
Studies in scope
all four open statuses
855
Recruiting now
open to new participants
341
Lead sponsors
across recruiting studies
Top sites
Vienna 23 Graz 14 Salzburg 11 Innsbruck 10 Linz 9

Trials in this register

27 of 1586 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Austria
Start
Recruiting
Eli Lilly and Company
Phase 2
606
Feldbach, Klagenfurt, Linz, Vienna
2026-08-07
Recruiting
Eli Lilly and Company
Phase 4
150
Salzburg
2026-03-09
Recruiting
Eli Lilly and Company
Phase 3
7,140
Feldkirch, Graz, Linz, Mattersburg, Sankt Stefan ob Stainz, Vienna
2025-12-01
Recruiting
Eli Lilly and Company
Phase 2
252
Vienna
2025-11-10
Recruiting
Eli Lilly and Company
Phase 3
1,630
Graz, Innsbruck, Vienna
2025-10-22
Recruiting
Eli Lilly and Company
Phase 3
4,500
Graz, Salzburg, Vienna, Wiener Neustadt
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Braunau am Inn, Feldkirch, Graz, Linz, Mattersburg, Mistelbach, Salzburg, Sankt Pölten
2025-09-02
Recruiting
Eli Lilly and Company
Phase 3
290
Graz, Innsbruck, Vienna
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Graz, Innsbruck, Vienna
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
700
Graz, Linz, Vienna
2025-03-27
Active, closed
Eli Lilly and Company
Phase 3
10,000
Braunau am Inn, Feldkirch, Graz, Innsbruck, Linz, Mattersburg, Sankt Stefan ob Stainz, Vienna
2024-04-30
Recruiting
Eli Lilly and Company
Phase 3
90
Vienna
2024-03-13
Active, closed
Eli Lilly and Company
Phase 3
17,300
Braunau am Inn, Feldkirch, Innsbruck, Linz, Mistelbach, Salzburg, Sankt Pölten, Vienna
2024-03-05
Recruiting
Eli Lilly and Company
Phase 3
1,264
Feldkirch, Linz, Vienna
2023-12-21
Active, closed
Eli Lilly and Company
Phase 3
15,374
Feldkirch, Graz, Innsbruck, Vienna
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Graz, Salzburg, Schwaz, Vienna
2022-10-04
Active, closed
Eli Lilly and Company
Phase 3
152
Feldkirch, Vienna
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
874
Vienna, Graz, Salzburg
2021-10-04
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
Eli Lilly and Company
Phase 3
150
Vienna
2021-05-26
Active, closed
Eli Lilly and Company
Phase 3
996
Salzburg, Vienna, Innsbruck
2020-06-22
Recruiting
Eli Lilly and Company
Phase 3
190
Bregenz
2019-04-05
Active, closed
Eli Lilly and Company
Phase 3
1,058
Innsbruck, Salzburg, Vienna
2018-07-18
Active, closed
Eli Lilly and Company
Phase 3
5,637
Vienna, Graz, Innsbruck, Schwaz, Salzburg
2017-07-12
Active, closed
Eli Lilly and Company
Phase 2
309
Wiener Neustadt, Salzburg, Vienna
2016-05-19
Active, closed
Eli Lilly and Company
Phase 3
493
Vienna, Graz, Innsbruck, Linz
2014-11-06
Active, closed
Eli Lilly and Company
Phase 3
453
Graz, Linz, Salzburg
2014-10-03
Active, closed
Eli Lilly and Company
Phase 2
110
Vienna
2012-05-22
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Austrian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-austria

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Austria and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,586 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Austria?

14 of the 27 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 27 studies
PhaseStudiesRecruitingShare
Phase 3221181.5%
Phase 24214.8%
Phase 4113.7%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Eli Lilly and Company2714

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Ulcerative Colitis (4) Crohn's Disease (4) Neoplasm Metastasis (3) Atherosclerotic Cardiovascular Disease (ASCVD) (3) Carcinoma, Non-Small-Cell Lung (3) Elevated Lp(a) (2) Breast Cancer (2) Obesity or Overweight (2) Breast Neoplasms (2) Ovarian Neoplasms (1) Fallopian Tube Neoplasms (1) Peritoneal Neoplasms (1) Atherosclerosis Cardiovascular Disease (1) Chronic Kidney Disease (1) Neoplasms, Hematologic (1)
→

Browse trials by site location

Vienna (23) Graz (14) Salzburg (11) Innsbruck (10) Linz (9) Feldkirch (7) Braunau am Inn (3) Sankt Pölten (2) Wiener Neustadt (2) Klagenfurt (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.